Characterisation of the prostanoid receptor mediating inhibition of smooth muscle contractility in the rat prostate gland

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 381, Issue 4, 2010, Pages 321-328

  Tokanovic, Slavko ^a   White, Carl W ^a   Malone, Daniel T ^a   Exintaris, Betty ^a   Ventura, Sabatino ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Cyclooxygenase; EP2 prostanoid receptor; Prostaglandins; Rat

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; 7 [5 (4 BIPHENYLYLMETHOXY) 2 MORPHOLINO 3 OXOCYCLOPENTYL] 4 HEPTENOIC ACID; ADENOSINE TRIPHOSPHATE; CYCLOOXYGENASE 2; NORADRENALIN; PROSTACYCLIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTANOID RECEPTOR; SULPROSTONE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRIC FIELD; ELECTROSTIMULATION; EVOKED MUSCLE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; ISOLATED ORGAN; MALE; NONHUMAN; PROSTATE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE RELAXATION;

ANIMALS; CYCLOOXYGENASE 2; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PROSTAGLANDINS; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN E;

EID: 77953233225     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-010-0492-y     Document Type: Article

References (20)

1. SP Alexander A Mathie JA Peters 2007 Guide to receptors and channels, 2nd edition (2007 revision) Br J Pharmacol 150 Suppl 1 S1 10.1038/sj.bjp.0707199 1:CAS:528:DC%2BD2sXhtlWnsr8%3D 17279063 (Pubitemid 46215412)
2. AF Badawi Y Liu MB Eldeen W Morrow ZR Razak M Maradeo MZ Badr 2004 Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer susceptible region of rat prostate Carcinogenesis 25 1681 1688 10.1093/carcin/bgh176 1:CAS:528:DC%2BD2cXntFahs70%3D 15117812 (Pubitemid 39214310)
3. S Bergstrom LA Carlson JR Weeks 1968 The prostaglandins: a family of biologically active lipids Pharmacol Rev 20 1 48 1:CAS:528:DyaF1cXktVSgtLk%3D 4873508
4. DL Clarke MA Giembycz HJ Patel MG Belvisi 2004 E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype Br J Pharmacol 141 600 609 10.1038/sj.bjp.0705648 1:CAS:528:DC%2BD2cXivVCmtbg%3D 14744812 (Pubitemid 38453251)
5. RA Coleman WL Smith S Narumiya 1994 International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes Pharmacol Rev 46 205 229 1:CAS:528:DyaK2cXlslSlsbo%3D 7938166
6. M Hasan F Parveen AK Shamsuzzaman MD Kibria 2007 Comparison of efficacy between tamsulosin and finasteride on symptomatic benign prostatic hyperplasia Mymensingh Med J 16 154 159 1:STN:280:DC%2BD2svosVKqsg%3D%3D 17703151
7. RL Jones MA Giembycz DF Woodward 2009 Prostanoid receptor antagonists: development strategies and therapeutic applications Br J Pharmacol 158 104 145 10.1111/j.1476-5381.2009.00317.x 1:CAS:528:DC%2BD1MXhsVKmu7bJ 19624532
8. S Kitada J Kumazawa 1987 Pharmacological characteristics of smooth muscle in benign prostatic hyperplasia and normal prostatic tissue J Urol 138 158 160 1:CAS:528:DyaL2sXkslWguro%3D 2439708
9. G Kramer D Mitteregger M Marberger 2007 Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 51 1202 1216 10.1016/j.eururo. 2006.12.011 1:CAS:528:DC%2BD2sXmsFOksL0%3D 17182170 (Pubitemid 46436310)
10. WA Lau S Ventura JN Pennefather 1998 Pharmacology of neurotransmission to the smooth muscle of the rat and the guinea pig prostate glands J Auton Pharmacol 18 349 356 10.1046/j.1365-2680.1998.1860349.x 1:CAS:528: DyaK1MXltFehtA%3D%3D 9915599
11. S Narumiya Y Sugimoto F Ushikubi 1999 Prostanoid receptors: structures, properties, and functions Physiol Rev 79 1193 1226 1:CAS:528:DyaK1MXmvVymtL0%3D 10508233
12. JE Oesterling 1995 Benign prostatic hyperplasia. Medical and minimally invasive treatment options N Engl J Med 332 99 109 10.1056/NEJM199501123320207 1:STN:280:DyaK2M%2Fot1yrtA%3D%3D 7527494
13. GP O'Neill AW Ford-Hutchinson 1993 Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues FEBS Lett 330 156 160 8365485
14. P Rigatti M Brausi RM Scarpa D Porru H Schumacher CA Rizzi 2003 A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia Prostate Cancer Prostatic Dis 6 315 323 10.1038/sj.pcan.4500680 1:CAS:528:DC%2BD3sXps1Siu74%3D 14663474 (Pubitemid 38088195)
15. MR Ruggieri Sr AS Braverman MA Pontari 2005 Combined use of alpha-adrenergic and muscarinic antagonists for the treatment of voiding dysfunction J Urol 174 1743 1748 10.1097/01.ju.0000176460.62847.23 1:CAS:528:DC%2BD2MXhtV2rt7vI 16217275 (Pubitemid 41546925)
16. A Sciarra F Di Silverio S Salciccia AMA Gomez A Gentilucci V Gentile 2007 Inflammation and chronic prostatic diseases: evidence for a link? Eur Urol 52 964 972 10.1016/j.eururo.2007.06.038 1:CAS:528:DC%2BD2sXht1WgurbF 17618043 (Pubitemid 47332058)
17. A Sciarra G Mariotti S Salciccia AMA Gomez S Monti V Toscano F Di Silverio 2008 Prostate growth and inflammation J Steroid Biochem Mol Biol 108 254 260 10.1016/j.jsbmb.2007.09.013 1:CAS:528:DC%2BD1cXhsFyntbk%3D 17935971 (Pubitemid 351179630)
18. K Sudoh O Inagaki K Honda 1997 Responsiveness of smooth muscle in the lower urinary tract of rabbits to various agonists Gen Pharmacol 28 629 631 1:CAS:528:DyaK2sXisFGmsLY%3D 9147036 (Pubitemid 27156930)
19. S Tokanovic DT Malone S Ventura 2007 Stimulation of epithelial CB1 receptors inhibits contractions of the rat prostate gland Br J Pharmacol 150 227 234 10.1038/sj.bjp.0706952 1:CAS:528:DC%2BD2sXotFertA%3D%3D 17099718 (Pubitemid 46160613)
20. S Ventura RK Dewalagama LC Lau 2003 Adenosine 5′-triphosphate (ATP) is an excitatory cotransmitter with noradrenaline to the smooth muscle of the rat prostate gland Br J Pharmacol 138 1277 1284 10.1038/sj.bjp.0705167 1:CAS:528:DC%2BD3sXjsFGiurk%3D 12711628 (Pubitemid 36543125)